Pulse photodynamic treatment of skin conditions

US2016346392A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016346392-A1
Application numberUS-201415103656-A
CountryUS
Kind codeA1
Filing dateDec 19, 2014
Priority dateDec 20, 2013
Publication dateDec 1, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A pulse photodynamic therapy (or pulse PDT) treatment of skin complaints is described herein. The skin complaint being treated can be actinic keratosis (AK) or a basal cell carcinoma (BCC).

First claim

Opening claim text (preview).

1 . A method of treating a skin condition in an animal the method comprising adminisering a photosensitizer to the animal skin, wherein the photosensitizer treats the skin condition with photodynamic therapy (PDT), and wherein the photosensitizer is applied to the skin of the animal for a short period of time, and the skin condition is actinic keratosis or basal cell carcinoma. 2 . The method according to claim 1 , wherein the method reduces side effects associated with PDT. 3 . The method according to claim 1 , further comprising applying the photosensitizer to the skin of the animal for a period of from 5 minutes to 120 minutes. 4 . The method according to claim 1 , wherein the PDT includes a photoactivation achieved by artificial or natural light source. 5 . The method according to claim 1 , wherein the PDT comprises: a) administering to the animal a composition comprising the photosensitizer for a duration of from 5 minutes to 120 minutes; and b) photoactivating the photosensitizer for a duration of from 1 minute to 15 minutes with artificial light or from 0.5 hour to 3 hours with natural light. 6 . The method according to claim 5 , wherein the PDT comprises: a) administering to the animal a composition comprising the photosensitizer for a duration of from 15 minutes to 60 minutes; and b) photoactivating the photosensitizer for a duration of from 5 minutes to 10 minutes with artificial light or from 0.5 hour to 2 hours with natural light. 7 . The method according to claim 6 , wherein PDT comprises: a) administering to the animal a composition comprising the photosensitizer for a duration of 30 minutes; and b) removing the photosensitizer; and c) photoactivating the photosensitizer 2.5 hours later for a duration of 9 minutes with artificial light or of at least 2 hours with natural light. 8 . The method according to claim 1 , wherein the photosensitizer is selected from the group consisting of 5-ALA, 5-ALA derivatives, 5-MAL, 5-MAL derivatives, and compounds covered by general formula I: R 2 2 N—CH 2 COCH 2 —CH 2 CO—OR 1   (I) wherein: R 1 represents a substituted or unsubstituted straight, branched or cyclic alkyl group; and each R 2 independently represents a hydrogen atom or an optionally substituted alkyl group; and pharmaceutically acceptable salts thereof. 9 . The method according to claim 1 , wherein the photosensitizer is 5-ALA or 5-methyl ALA ester. 10 . The method according to claim 1 , wherein administering the photosensitizer to the animal is carried out with or without occlusion. 11 . The method according to claim 1 , wherein the photosensitizer is used in combination with a glucocorticosteroid. 12 . The method according to claim 3 , wherein the period of time is from 15 minutes to 60 minutes. 13 . The method according to claim 4 , wherein the artificial or natural light source is a LED or sunlight. 14 . The method according to claim 8 , wherein the alkyl group is a substituted or unsubstituted straight-chained alkyl group. 15 . The method according to claim 10 , wherein the administration of the photosensitizer is carried out with occlusion.

Assignees

Inventors

Classifications

  • Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title

  • Antineoplastic agents · CPC title

  • for treating wounds, ulcers, burns, scars, keloids, or the like · CPC title

  • Emollients or protectives, e.g. against radiation · CPC title

  • Anti-acne agents · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016346392A1 cover?
A pulse photodynamic therapy (or pulse PDT) treatment of skin complaints is described herein. The skin complaint being treated can be actinic keratosis (AK) or a basal cell carcinoma (BCC).
Who is the assignee on this patent?
Galderma Res & Dev
What technology area does this patent fall under?
Primary CPC classification A61K41/0061. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Dec 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).